The Roles of Age, Comorbidity, and Telomere Length in Lung Cancer Treatment and Prognosis

Dynamic Changes of Circulating Tumor DNA in Surgical Lung Cancer Patients

NCT02965391 ·Status: COMPLETED

Multinational Observational Study to Describe Diagnostic Stage Shift in Patients With Lung Cancer Using Medical Records

NCT06842056 ·Status: NOT_YET_RECRUITING

Machine Learning to Construct an Association Model for Lung Cancer and Environmental Hormone

NCT06259461 ·Status: ACTIVE_NOT_RECRUITING

Non-Invasive ctDNA Methylation Detection for Lung Nodule Patients

NCT03685669 ·Status: UNKNOWN

Folate One-carbon Malnutrition as the Metabostemness Risk Factor of Malignancy Tumor Development of NSCLC Patients

NCT03504098 ·Status: UNKNOWN

The Role of Microbiota on the Development of Lung Cancer

NCT03454685 ·Status: UNKNOWN

Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer

NCT00923884 ·Status: COMPLETED

Preoperative and Postoperative ctDNA Comparison in Early Stage Lung Cancer

NCT03805256 ·Status: UNKNOWN

ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS

NCT03172156 ·Status: COMPLETED

Develop and Test the Effects of the 'Computer-Assisted OPD COPSCCP on Early Stage Lung Cancer Patients

NCT04506359 ·Status: RECRUITING ·Phase: NA

Genotyping of Non-small Cell Lung Cancer

NCT02002117 ·Status: UNKNOWN

Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer

NCT01004601 ·Status: COMPLETED ·Phase: NA

Usefulness of Blood Biomarkers for Overall Survival in NSCLC

NCT01936571 ·Status: COMPLETED

Comparison of Cost-effectiveness of Continuation Maintenance Therapy With Six Cycles of Pemetrexed Versus Pemetrexed Until Disease Progression for Metastatic Non-squamous Non-small-cell Lung Cancer

NCT02397239 ·Status: UNKNOWN

Molecular Subtyping of Extensive Stage Small Cell Lung Cancer and Relevent Clinical Significance

NCT05933863 ·Status: COMPLETED

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

NCT04566432 ·Status: RECRUITING

Lung Cancer Patients and Parent-child Interaction Experience and Process

NCT06823505 ·Status: TERMINATED

Combined Relapse Prediction Model for Resectable Non-Small Cell Patients - a Prospective Clinical Feasibility Trial

NCT06262386 ·Status: RECRUITING ·Phase: NA

Correlation Between EGFR Mutation Using cfDNAs and Circulating Tumor Cells in Patients With NSCLC

NCT02422628 ·Status: UNKNOWN

Incidence and Characterization of Drivers Oncogenes in the Population With Lung Cancer Afferents to the Cancer Institute in Aviano (IN.ON.D.)

NCT06180005 ·Status: RECRUITING

Care Needs in Lung Cancer Patients Receiving Immunotherapy

NCT06433206 ·Status: RECRUITING

Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLC

NCT07186855 ·Status: COMPLETED

Change in NLR and Survival Among Advanced Lung Cancer Patients Receiving ICIs With Immunomodulator

NCT04352335 ·Status: COMPLETED

The Impact of M1/M2 Tumor Associated Macrophage (TAM) Polarization on Cancer Progression and Prognosis Prediction

NCT00690261 ·Status: UNKNOWN

cfDNA Methylation Assay for Clinical Evaluation of Patients With Stage IA Lung Cancer After Ablation Operation

NCT04413656 ·Status: UNKNOWN ·Phase: NA